| __timestamp | ACADIA Pharmaceuticals Inc. | Amicus Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 20717000 |
| Thursday, January 1, 2015 | 90804000 | 47269000 |
| Friday, January 1, 2016 | 186456000 | 71151000 |
| Sunday, January 1, 2017 | 255062000 | 88671000 |
| Monday, January 1, 2018 | 265758000 | 127200000 |
| Tuesday, January 1, 2019 | 325638000 | 169861000 |
| Wednesday, January 1, 2020 | 388661000 | 156407000 |
| Friday, January 1, 2021 | 396028000 | 192710000 |
| Saturday, January 1, 2022 | 369090000 | 213041000 |
| Sunday, January 1, 2023 | 402466000 | 275270000 |
Unlocking the unknown
In the competitive world of biotechnology, understanding spending patterns can offer valuable insights into a company's strategic priorities. Over the past decade, ACADIA Pharmaceuticals Inc. and Amicus Therapeutics, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses.
From 2014 to 2023, ACADIA Pharmaceuticals has consistently increased its SG&A spending, peaking in 2023 with a 23% rise from 2020. This upward trend reflects ACADIA's aggressive market expansion and investment in administrative capabilities. In contrast, Amicus Therapeutics, while also increasing its SG&A expenses, has done so at a more moderate pace, with a 76% increase over the same period. This suggests a more cautious approach, possibly focusing on sustainable growth and operational efficiency.
These spending patterns not only highlight the companies' differing strategies but also provide a window into their future trajectories in the biotech landscape.
Intra-Cellular Therapies, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Bio-Techne Corporation or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.
CymaBay Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing PTC Therapeutics, Inc. and Amicus Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ACADIA Pharmaceuticals Inc.
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Amicus Therapeutics, Inc.
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of MorphoSys AG and Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Breaking Down SG&A Expenses: Amicus Therapeutics, Inc. vs MannKind Corporation